EUVIMEDEUVIMED entdecken
Crossref

Testosterone Therapy Did Not Increase Major Cardiovascular Events

Emily Harris

JAMA · 2023

DOI: 10.1001/jama.2023.11959 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA, 2023. Verfasst von Emily Harris. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Hypogonadism, Testosterone.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Major Cardiovascular Events Men who received testosterone therapy for an average of about 22 months did not experience a greater number of major adverse cardiac events compared with those who received a placebo, based on results from a randomized clinical trial that enrolled 5246 patients aged 45 to 80 years. All participants had low levels of testosterone as well as symptoms of underfunctioning gonads—such as decreased libido, low mood, or loss of body hair—in addition to a preexisting or high risk of cardiovascular disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesHypogonadismTestosteroneHumansAndrogensHormone Replacement TherapyRisk FactorsMale

Substanzen

AndrogensTestosterone

Zitieren

APA

Harris, E. (2023). Testosterone Therapy Did Not Increase Major Cardiovascular Events. JAMA. https://doi.org/10.1001/jama.2023.11959

Vancouver

Harris E. Testosterone Therapy Did Not Increase Major Cardiovascular Events. JAMA. 2023. doi:10.1001/jama.2023.11959

BibTeX
@article{Harris2023,
  author = {Harris, Emily},
  title = {Testosterone Therapy Did Not Increase Major Cardiovascular Events},
  journal = {JAMA},
  year = {2023},
  doi = {10.1001/jama.2023.11959}
}
Kostenlos starten →